Novel treatment for T-cell leukemias and lymphomas demonstrates promise in preclinical study

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Vasan Yegnasubramanian, MD, PhD, is the director of Precision inHealth Medicine at Johns Hopkins. He spoke with Johns Hopkins Kimmel Cancer Center communications staff about how AI is transforming cancer research and treatment. The transcript of the conversation follows.

March 06, 2026

Vol.52 No.09

By John’s Hopkins Kimmel Cancer Center Communications

Clinical Roundup

Johns Hopkins investigators create open source database to more easily study cancer data

Researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily study multiple types of cancer data—including laboratory results, genetic sequencing and imaging data—in one setting.

March 06, 2026

Vol.52 No.09

Clinical Roundup

AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence-based liquid biopsy test using genome-wide cell-free DNA fragmentation patterns and repeat landscapes can detect early liver fibrosis and cirrhosis, and may also reveal signals of broader chronic disease burden.

March 06, 2026

Vol.52 No.09

Clinical Roundup

Cell-free DNA offers early warning for bloodstream infections in children with leukemia, St. Jude-led study finds

A study led by researchers at St. Jude Children’s Research Hospital shows that microbial cell-free DNA sequencing can predict bloodstream infections in children with leukemia days before the infection is apparent.

March 06, 2026

Vol.52 No.09

Clinical Roundup

Follicular lymphoma may be curable with chemoimmunotherapy combo, data from 15-year trial suggests

Long-term data on patients treated with a standard chemoimmunotherapy combination show relapse rates dropped over time and 70% of patients were still alive 15 years later, with an overall cure rate estimated at 42% of patients treated, according to a study led by scientists at SWOG, Fred Hutch Cancer Center, and the University of Rochester Medical Center.

February 27, 2026

Vol.52 No.08

Black History Month Podcast

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

Malcolm V. Brock, director of Clinical and Translational Research in Thoracic Surgery at Johns Hopkins Kimmel Comprehensive Cancer Center, grew up in Bermuda. His father insisted that his children branch outside the small island—the country has a population of just over 60,000 people—and challenge themselves abroad.

February 20, 2026

Vol.52 No.07

By Malcolm V. Brock, Robert A. Winn and Preston Willett

Novel treatment for T-cell leukemias and lymphomas demonstrates promise in preclinical study

YOU MAY BE INTERESTED IN

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Johns Hopkins investigators create open source database to more easily study cancer data

AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

Cell-free DNA offers early warning for bloodstream infections in children with leukemia, St. Jude-led study finds

Follicular lymphoma may be curable with chemoimmunotherapy combo, data from 15-year trial suggests

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

Renew today!

Subscriber content

Never miss an issue!

Login

Novel treatment for T-cell leukemias and lymphomas demonstrates promise in preclinical study

YOU MAY BE INTERESTED IN

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Johns Hopkins investigators create open source database to more easily study cancer data

AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

Cell-free DNA offers early warning for bloodstream infections in children with leukemia, St. Jude-led study finds

Follicular lymphoma may be curable with chemoimmunotherapy combo, data from 15-year trial suggests

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology“When it gets down to brass tacks, relationships between each other, we’re all one.”

Never miss an issue!

Login

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”